September 25, 2007 - Abbott Laboratories said it is working with the FDA Administration to schedule an advisory panel ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
September 24, 2007 - Stentys announced that its drug-eluting bifurcated stent for treatment of blocked coronary artery ...
September 21, 2007-The CYPHER Sirolimus-eluting Coronary Stent reduced by more than half the rate of major adverse ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 18, 2007 - Angiotech Pharmaceuticals Inc. announced that it reached a favorable agreement with Johnson & ...
September 14, 2007 - In the largest study of its kind to date, comparing the CYPHER Sirolimus-eluting Coronary Stent and ...
iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the ...
September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...
September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES ...
September 6, 2007 – Boston Scientific Corp. announced at the ESC 2007 conference in Vienna, Austria, that results from ...
September 5, 2007 – According to Boston Scientific Corp., results from the TAXUS WOMAN study, a gender specific analysis ...
September 5, 2007 - Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) ...
September 4, 2007 - Analysis of clinical trials showed the Cypher Sirolimus-eluting coronary stent was associated with ...
August 28, 2007 – The FDA Advisory Panel will review the Premarket Approval (PMA) application for Endeavor Drug Eluting ...
August 22, 2007 - Medtronic, Inc. announced it has been informed by the FDA that an Advisory Panel will review the ...